Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from IDT Australia Limited ( (AU:IDT) ) is now available.
IDT Australia Limited has issued 348,400 Ordinary Shares without disclosure to investors under the Corporations Act, confirming compliance with relevant provisions and indicating no undisclosed ‘excluded information’. This move reflects IDT’s strategic financial maneuvers to potentially enhance its market positioning and operational capabilities, impacting stakeholders by maintaining transparency and regulatory adherence.
More about IDT Australia Limited
IDT Australia Limited (ASX: IDT) is an Australian pharmaceutical manufacturing company located in Boronia, Victoria. The company specializes in the development and production of high potency and high containment pharmaceutical products for both local and international clients. IDT’s facilities are cGMP compliant and regularly audited by the US FDA and Australian TGA, offering comprehensive services in new drug development, scale-up, and commercial active drug manufacturing, including a variety of oral and injectable finished drug dose forms.
Average Trading Volume: 215,892
Technical Sentiment Signal: Sell
Current Market Cap: A$26.86M
For a thorough assessment of IDT stock, go to TipRanks’ Stock Analysis page.